2      0

ODADV01 - Emerging Treatment Paradigms for Kidney Cancer

‐ Apr 16, 2021 5:00am

Credits: None available.

This presentation covers the anatomy, epidemiology, histology, risk factors, clinical presentation, workup, staging, and management options for all stages of kidney cancer with a focus on new and emerging treatment strategies utilizing stereotactic radiation and immunotherapy.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 4/18/23.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Committee Disclosures:

Julie A. Starr, PhD, APRN – Consultant for The Prometheus Group

There are no other Planning Committee disclosures to declare.

Speakers Conflict of Interest Disclosure:
There are no speaker disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.

Learning Outcome:

After completing this education activity, the learner will be able to include kidney cancer in their differential diagnosis of appropriate patients for each stage of kidney cancer.


Credits Available

You must be logged in and own this session in order to post comments.

Nancy Boesen
9/12/21 10:23 am

I found a good deal of clarification on renal cell and how it is done